Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Digestive Endoscopy

• Publication date

  2016-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/den.12553PMID 26418574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.

  2015cited by this paper
• Immunostimulatory Effects Triggered by Enterococcus faecalis CECT7121 Probiotic Strain Involve Activation of Dendritic Cells and Interferon-Gamma Production

  2015cited by this paper
• Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study.

  2014cited by this paper
• Dose-Dependent Effects of Lactobacillus rhamnosus on Serum Interleukin-17 Production and Intestinal T-Cell Responses in Pigs Challenged with Escherichia coli

  2014cited by this paper
• Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.

  2013cited by this paper
• Dose-Dependent Immunomodulation of Human Dendritic Cells by the Probiotic Lactobacillus rhamnosus Lcr35

  2011cited by this paper
• Correspondence to Author:

  2010cited by this paper
• The potential of probiotics: a review.

  2010cited by this paper
• Mechanisms of probiotic actions - A review.

  2010cited by this paper
• A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis.

  2009cited by this paper
• Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis.

  2009cited by this paper
• Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.

  2008cited by this paper
• Probiotics, prebiotics, and synbiotics.

  2008cited by this paper
• A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.

  2007cited by this paper
• Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair

  2007cited by this paper
• Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

  2006cited by this paper
• An unusual cause of soft tissue infection

  2005cited by this paper
• Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

  2005cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• Review article: monitoring activity in ulcerative colitis.

  2002cited by this paper
• Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics

  1999cited by this paper
• Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

  1989cited by this paper
• Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

  1987cited by this paper

• Redrawing the gut map: evolving probiotic approaches to microbiota modulation in inflammatory bowel disease

  2026cites this paper
• Hemp seed mitigates colonic inflammation through macrophage polarization and microbiota-barrier axis restoration.

  2025cites this paper
• A social-architecture perspective on gut microbiota dynamics and host physiology

  2025cites this paper
• Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management

  2025cites this paper
• Targeting Kidney Inflammation in Colitis: The Role of Probiotics, Paraprobiotics, and Autophagy.

  2025cites this paper
• Exploring the Potential of Biotics in Cancer Prevention and Treatment—Mechanisms, Experimental, and Clinical Insights

  2025cites this paper
• A multi-strain probiotic formulation preserves intestinal epithelial and vascular barriers during enteropathogenic infection

  2025cites this paper
• Therapeutic Potential of Short-Chain Fatty Acids in Gastrointestinal Diseases

  2025cites this paper
• Recent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of Diseases

  2025cites this paper
• Long-term arsenic exposure perturbs gut microbial diversity, composition and predicts metabolic dysregulation.

  2025cites this paper
• Therapeutic Potential of Probiotics: A Review of Their Role in Modulating Inflammation.

  2025cites this paper
• New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites

  2025cites this paper
• Anti-inflammatory effect of food bioactives in Inflammatory Bowel Disease: Role of the gut microbiome

  2025cites this paper
• Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment

  2025cites this paper
• A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1

  2025cites this paper
• Targeting gut microbiota dysbiosis in inflammatory bowel disease: a systematic review of current evidence

  2025cites this paper
• A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth

  2025cites this paper
• Genome-Resolved in Silico Analysis of Poultry and Swine Lactobacillales Provides a Data-Driven Framework for Elucidating Metabolic Complementary interactions in Multi-Strain Probiotics.

  2025cites this paper
• Probiotics and diet quality: modulation of gut microbiota on intestinal infection and inflammation

  2025cites this paper
• Prebiotics and Probiotics for Gastrointestinal Disorders

  2024cites this paper
• Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

  2024cites this paper
• Additive efficacy and safety of probiotics in the treatment of ulcerative colitis: a systematic review and meta-analysis

  2024cites this paper
• What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?

  2024cites this paper
• Probiotics Application in the Treatment of Autoimmune Diseases and Enhancement of Efficacy Through Genetic Engineering

  2024cites this paper
• Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis

  2024cites this paper
• Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy

  2024cites this paper
• The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases

  2024cites this paper
• The Role of Gut Microbiota, Immune System, and Autophagy in the Pathogenesis of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutic Approaches

  2024cites this paper
• Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction

  2024cites this paper
• Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections

  2024cites this paper
• Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies

  2024cites this paper
• Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta‐analysis of randomized controlled trials

  2024cites this paper
• Guía colombiana para el uso de probióticos en patologías pediátricas

  2024cites this paper
• Dietary purple potatoes shape gut microbiota and ameliorate colitis in IL-10-deficient mice

  2024cites this paper
• Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains

  2024cites this paper
• A Comprehensive Analysis of Efficacy and Safety of Probiotics in Inflammatory Bowel Disease

  2024cites this paper
• The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review

  2024cites this paper
• Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods.

  2024cites this paper
• Probiotic properties and the ameliorative effect on DSS-induced colitis of human milk-derived Lactobacillus gasseri SHMB 0001.

  2024cites this paper
• Probiotics for inflammatory bowel disease: Is there sufficient evidence?

  2024cites this paper
• From gut to brain: understanding the role of microbiota in inflammatory bowel disease

  2024cites this paper
• Bifidobacterium longum subsp. infantis FJSYZ1M3 ameliorates DSS-induced colitis by maintaining the intestinal barrier, regulating inflammatory cytokines, and modifying gut microbiota.

  2023cites this paper
• Bacteroides thetaiotaomicron and its inactivated bacteria ameliorate colitis by inhibiting macrophage activation.

  2023cites this paper
• Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives

  2023cites this paper
• Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis

  2023cites this paper
• A review on the use of prebiotics in ulcerative colitis.

  2023cites this paper
• Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis

  2023cites this paper
• Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

  2023cites this paper
• Dysbiosis of gut microbiota in patients with protein-losing enteropathy after the Fontan procedure.

  2023cites this paper
• Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease

  2023cites this paper
• Propionic Acid Driven by the Lactobacillus johnsonii Culture Supernatant Alleviates Colitis by Inhibiting M1 Macrophage Polarization by Modulating the MAPK Pathway in Mice.

  2023cites this paper
• Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis

  2023cites this paper
• Systematic review: does the use of probiotics generate benefits for patients treating inflammatory intestinal disease?

  2023cites this paper
• Does probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled study

  2023cites this paper
• Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia

  2023cites this paper
• Prevention of DSS-induced colitis in mice with water kefir microbiota via anti-inflammatory and microbiota-balancing activity.

  2023cites this paper
• Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective

  2023cites this paper
• Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022

  2023cites this paper
• The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease

  2023cites this paper
• Exploiting lactic acid bacteria for inflammatory bowel disease: A recent update

  2023cites this paper
• Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models

  2023cites this paper
• Gut microbiome–based therapeutics in inflammatory bowel disease

  2023cites this paper
• Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond

  2023cites this paper
• The Crosstalk between Intestinal Epithelial Cells and Mast Cells Is Modulated by the Probiotic Supplementation in Co-Culture Models

  2023cites this paper
• The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature

  2023cites this paper
• The Potential Therapeutic Role of Lactobacillaceae rhamnosus for Treatment of Inflammatory Bowel Disease

  2023cites this paper
• ESPEN guideline on Clinical Nutrition in inflammatory bowel disease.

  2023cites this paper
• Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves’ Disease Before and After Methimazole Treatment

  2022cites this paper
• The role of probiotics in nutritional health: probiotics as nutribiotics

  2022cites this paper
• Probiotics: current regulatory aspects of probiotics for use in different disease conditions

  2022cites this paper
• Therapeutic applications of probiotics and its regulatory framework

  2022cites this paper
• Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update

  2022cites this paper
• Probiotics in the Treatment of Inflammatory Bowel Disease in Adulthood: A Systematic Review.

  2022influential citation
• Bifidobacterium spp. as functional foods: A review of current status, challenges, and strategies

  2022cites this paper
• The fermented soy whey produced by a combined lactic acid bacteria starter shows improved flavor and the function in alleviating dextran sulphate sodium induced colitis in mice

  2022cites this paper
• Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study

  2022cites this paper
• Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?

  2022cites this paper
• Gut microbiome and autoimmune disorders.

  2022cites this paper
• British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease

  2022cites this paper
• Lactobacillus rhamnosus sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics

  2022cites this paper
• Prebiotics, Probiotics, and Postbiotics in the Prevention and Treatment of Anemia

  2022cites this paper
• Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

  2022cites this paper
• Short‐chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?

  2022cites this paper
• Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”

  2022cites this paper
• Role of lactobacillus strains in the management of colorectal cancer: An overview of recent advances.

  2022cites this paper
• Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis

  2022cites this paper
• Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study.

  2022cites this paper
• A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins

  2022cites this paper
• Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

  2022cites this paper
• The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A

  2022cites this paper
• Probiotics and gastrointestinal diseases.

  2022cites this paper
• Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies

  2022cites this paper
• Novel Phocaeicola Strain Ameliorates Dextran Sulfate Sodium-induced Colitis in Mice

  2022cites this paper
• Autoimmune-associated genetics impact probiotic colonization of the infant gut.

  2022cites this paper
• Lactobacillus gasseri JM1 Isolated from Infant Feces Alleviates Colitis in Mice via Protecting the Intestinal Barrier

  2022cites this paper
• Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body

  2021cites this paper
• Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

  2021cites this paper
• Bacteroides ovatus promotes IL-22 production and reduces trinitrobenzene sulfonic acid (TNBS)-driven colonic inflammation.

  2021cites this paper
• A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1

  2021cites this paper
• Identification of the key characteristics of Bifidobacterium longum strains for the alleviation of ulcerative colitis.

  2021cites this paper